Research Awards
About Us

Support Us

Research Awards
   Award Recipients
   Apply for an Award

   Clinical Network
   Preclinical Screening

News Room
   What's New
   Advance Newsletter
   In the News
   Media Kit

   Clinical Trials
   Additional Resources

Contact Us


The Hawaii Bicycling League's annual Haleiwa Metric Century bicycling event was a terrific success!

More than 900 riders, volunteers and supporters gathered on the North Shore of Oahu on the morning of April 29th.

This year's Haleiwa Metric Century was dedicated to John B. Kelley, former board chair and supporter of the Hawaii Bicycling League. John had a glioblastoma multiforme (GBM), the most aggressive form of brain cancer and passed away in 2006. In his honor, the Hawaii Bicycling League encouraged participants and supporters to become Haleiwa Superheroes by making a donation to Accelerate Brain Cancer Cure, with all proceeds supporting GBM research.

All of the funds raised from this event will support our work to hasten a cure for brain cancer. Dan Case, Sr., father of Accelerate Brain Cancer Cure founders Dan and Steve Case and Hawaii resident, addressed the cyclist and expressed the organization's gratitude for including Accelerate Brain Cancer Cure as a charitable partner. Accelerate Brain Cancer Cure continues to accept donations in memory of John B. Kelley.

Mahalo nui loa to our friends in Hawaii!

Hawaii Bicycling League was established as a non-profit 501(c)(3) corporation in December 1975. HBL's mission is to support a safe and desirable bicycling environment in Hawaii promoting bicycling as a recreational activity, competitive sport, and means of transportation. We pursue our mission through public education, policy advocacy, and special events.

If you are interested in starting an event or supporting an existing event to help find a cure for brain cancer, please contact Shannon Sullivan, Accelerate Brain Cancer Cure Director of Development (202.419.3140 or [email protected]).
Content copyright © 2008 Accelerate Brain Cancer Cure, Inc.